Published in Food and Drug Law Weekly, April 13th, 2007
"I'm very pleased with the addition of Dr. Mark Bossie to the PhytoMedical team," commented PhytoMedical President and CEO, Mr. Greg Wujek. "Mark's very special expertise with novel pharmaceutical compounds is particularly helpful as we work towards expanding the Company's drug discovery pipeline, while continuing to move our new class of compounds for type-2 diabetes towards an Investigative New Drug application with the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.